Global Neurology Devices Market
show more| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Nerve Repair & Regeneration Market 2013年，神经修复和再生市场占据4680.82亿美元，预计到2018年的价格为8112.19百万美元，增长11.6％。神经调节市场是全面神经修复和再生市场的45亿美元的最大段。神经修复和再生市场细分包括直接神经修复，神经移植和干细胞疗法，而神经调节细分包括脊髓刺激（SCS），深脑刺激（DBS），迷走神经刺激（VNS）等内部刺激装置，骶神经刺激（SNS），胃刺激（GES）和外部刺激装置，如经颅磁刺激（TMS）和经皮电子神经刺激（TENS）。在周围神经修复部门运营的主要公司包括Integla Lifesciences Corporation（美国），Stryker Corporation（美国），Axologen，Inc。（美国）和Polymanics（荷兰）。The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
全球性神经刺激/神经调节市场 预计2013年全球性神经调节/神经调节市场将于2018年在11.6％的CAGR中达到2013年的4503.9百万美元至7810.4百万美元。神经调节市场是最大的96％的神经修复和再生市场。该市场除以2个细分，如内部神经调节和外部神经调节。内部神经调节装置市场包括脊髓刺激（SCS），深脑刺激（DBS），迷走神经刺激（VNS），骶神经刺激（SNS），胃电刺激（GES），以及外部神经调节装置，如经颅磁刺激（TMS）和经皮电子神经刺激（TENS）。Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
北美神经维修和再生市场 北美神经修复和再生arket was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Apr 2015 |
|
欧洲神经维修和再生市场 The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. |
Apr 2015 |
|
Asian Nerve Repair & Regeneration Market 亚洲神经修复和再生市场于2013年以4680.82亿美元的价格挂钩，预计到2018年的价格为8112.19百万美元，增长了11.6％。市场部分包括直接神经修复，神经移植和干细胞疗法，而神经调节细分包括内部刺激装置，如脊髓刺激（SCS），深脑刺激（DBS），迷走神经刺激（VNS），骶神经刺激（SNS），胃电刺激（GES）和外部刺激装置，例如经颅磁刺激（TMS）和经皮电子神经刺激（TENS）。在周围神经修复部门运营的主要公司包括Integla Lifesciences Corporation（美国），Stryker Corporation（美国），Axologen，Inc。（美国）和Polymanics（荷兰）。The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Mar 2015 |
|
亚洲内部神经刺激 亚洲内部神经刺激市场于2013年为271.80万美元，预计到2018年的CAGR达到15.0％的546.6百万美元。内部神经刺激市场由5种方式分割包括脊髓刺激（SCS），深脑刺激（DBS），迷走神经刺激（VNS），骶神经刺激（SNS），胃电刺激（GES）。主要球员统治内部神经刺激市场是Medtronic，Inc。 |
Mar 2015 |
|
全球内部神经刺激市场 2013年内部神经刺激市场为390.32百万美元，预计到2018年的CAGR达到11.8％的价格为6828.8百万美元。内部神经调节市场是总体神经调节市场的最大段87％。内部神经刺激市场由5种方式分割包括脊髓刺激（SCS），深脑刺激（DBS），迷走神经刺激（VNS），骶神经刺激（SNS），胃电刺激（GES）。主要球员占据内部神经刺激市场包括Medtronic，波士顿科学，圣裘德医疗，网络蚀剂，肠球，神经技术，遗传，微转运和生物控制医疗。 |
Apr 2015 |
|
欧洲内部神经刺激 The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited. |
Upcoming |
|
North American Internal Neurostimulation The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical. |
Upcoming |
|
Asian Neurostimulation/Neuromodulation devices Market The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
欧洲神经刺激/神经调节装置市场 该报告还提供了在该市场中运营的公司的详细竞争景观。报告中详细说明，分段和特定于国家/地区的公司股份，新闻和特许，并购案特定的管道产品，产品批准和产品回忆。Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market. |
May 2015 |
|
北美内部神经调节装置市场 北美神经调节市场已被程序，模态和地理分段。在程序的基础上，市场进一步分段为内部和外部刺激。内部刺激细分占神经调节市场的87.4％。基于偶数的市场涵盖了内部和外部的方式。内部模态分部占神经调节市场的85.9％。 |
May 2015 |
|
脑监测设备 The Global Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The global brain monitoring market was valued at $1164.05 million in 2013 and is poised to grow at a CAGR of 8.6% to reach $1639.4 million by 2018. The Brain Monitoring Devices Market segmentation by products such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories & by Application Sleep Disorders, Epilepsy, Traumatic Brain Injury, Brain Death. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
Neurointerventional Device Market 2013年全球神经磁控设备市场估计为1544.79百万美元，预计到2018年的复合年增长率为6.8％，以达到1.944.7百万美元。神经永久性设备在5个段（如神经大学设备（吸入/抽吸装置，凝块）等5个细分市场分割猎犬和陷阱装置），脑血管造影和支架系统（颈动脉支架和栓塞保护系统），动脉瘤卷绕装置（铂卷，液体栓塞剂和流动导流装置）和支撑装置（微导管和微织物）。在这份报告中广泛涵盖的主要球员是Covidien，Plc（爱尔兰），Stryker Corporation（美国），Johnson＆Johnson（美国），佩曼，Inc。（美国）。 |
Upcoming |
|
脑电图（EEG） 大脑/精神疾病发病率的上升,ong with the phenomenal growth of brain monitoring devices in Asia is expected to drive the rapid progression of the global electroencephalograph market. The global market is projected to grow at a CAGR of 9.8%, from 2013 to 2018. The market report provides insights into the market value forecasts, segmentation, drivers & restraints, opportunities for new entrants, and the competitive scenario in the market. North America, Europe, Asia, and RoW are the major regions considered for the extensive market analysis. |
Upcoming |
|
Transcranial Dopplers (TCD) The growing investments in the healthcare sector, which aims to enhance mental healthcare delivery, along with the rising incidence of mental/brain disorders among the aging population in North America, Europe, and Japan are major driving factors of the global transcranial doppler market. The market report provides details of market segmentation, drivers & restraints, competitive scenario, and opportunities for new entrants. North America, Europe, Asia, and Rest of the World are geographical regions considered for market analysis. |
Upcoming |
|
Magnetoencephalograph (MEG) 世界各大地区的大脑/精神障碍越来越多，以及越来越多地投资脑监测设备的研发，是全球磁道素市场的主要驱动因素。北美分部是全球市场的最大贡献者，2013年占52.27％。预计亚洲市场将是2013年至2018年的复合年增长率最快的市场部门。该报告提供了一个7.8％。该报告提供了一个市场份额，价值链分析和市场指标综合概述，如司机，克制和即将到来的机会。北美，欧洲，亚洲和世界又居住是市场分析所考虑的主要区域。 |
Upcoming |
|
颅内压力监测器 The Intracranial Pressure Monitors market was valued at $192.49 million in 2013, and is poised to grow at a CAGR of 7.4%, to reach $275.04 million by 2018. Major players in intracranial pressure monitors market are Integra Life Sciences Corporation (U.S.) and DePuy Synthes (U.S.) are the leading players in this market. The other prominent players are Spiegelberg GmbH (Germany), InnerSpace Neuro, Inc. (U.S.), and HeadSense Medical, Ltd. (Israel). |
Upcoming |
|
脑血管计 The Global Cerebral Oximeters Devices Market is mainly driven by cardiac/vascular surgery, shoulder surgery, single lung ventilation, and various other surgical procedures. The global cerebral oximeters market was valued $80.42 million in 2013, and is estimated to reach $112.0 million by 2018, at a CAGR of 6.80%. The prominent players in the cerebral oximeters market are Covidien, PLC (Ireland), Nonin Medical (U.S.), and CAS Medical systems (U.S.). |
Upcoming |
|
神经疾病设备 神经疾病装置和脑筋气谐血管成形术和止损的系统， |
Upcoming |
神经病学器件市场
